| human | Q5 |
| P496 | ORCID iD | 0000-0001-5053-0390 |
| P735 | given name | Susan | Q14936243 |
| Susan | Q14936243 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q70929979 | A 45-year follow-up of kindred 107 and the search for BRCA2 |
| Q27851690 | A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer |
| Q59548837 | A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1 |
| Q40495288 | A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer |
| Q59355837 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk |
| Q28200053 | A candidate prostate cancer susceptibility gene at chromosome 17p |
| Q46533348 | A comparison of bilateral breast cancers in BRCA carriers |
| Q26829268 | A guide for functional analysis of BRCA1 variants of uncertain significance |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q36152991 | A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers |
| Q72297590 | A physical map encompassing GP2B, EPB3, D17S183, D17S78, D17S1183, and D17S1184 |
| Q37719595 | A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers |
| Q34385903 | A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes |
| Q30757700 | A strategy for high throughput HLA-DQ typing |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q37417780 | AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study |
| Q57903143 | Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22 |
| Q57907595 | Abstract 1291: High and moderate penetrance germline mutations in a number of genes are responsible for a small proportion of familial breast cancer risk in BRCAx families |
| Q57907601 | Abstract 2378: Harmonization of next generation sequencing data within consortia for gene discovery in familial breast cancer |
| Q57907603 | Abstract 3282: Determination of cancer susceptibility in probands with breast and ovarian cancer |
| Q55615119 | Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. |
| Q57266698 | Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q88723598 | Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q59238426 | Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q35659388 | Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study |
| Q88791860 | Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation |
| Q37041238 | Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study |
| Q37129674 | Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers |
| Q46452127 | An autosomal genome-wide screen for celiac disease in Bedouin families |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q35618307 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
| Q47564486 | Are VNTRs co-localizing with breast cancer-associated SNPs? |
| Q28168116 | Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway |
| Q35242849 | Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q34277534 | Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci |
| Q27851709 | Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer |
| Q91271723 | Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness |
| Q36178189 | Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q34135443 | Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality |
| Q35957703 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer |
| Q46877011 | Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. |
| Q44592775 | Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer |
| Q37403674 | Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival |
| Q35523236 | Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q60907509 | Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q35350825 | BRCA1 Circos: a visualisation resource for functional analysis of missense variants |
| Q37416050 | BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research |
| Q71696011 | BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q71167609 | BRCA2 germline mutations in male breast cancer cases and breast cancer families |
| Q40592257 | Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers |
| Q35633111 | Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study |
| Q47189470 | Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group |
| Q51715408 | Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q35925255 | Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers |
| Q31926021 | Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. |
| Q53265333 | Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q57305977 | Breast-Cancer Risk in Families With Mutations in PALB2 |
| Q34148873 | Breast-cancer risk in families with mutations in PALB2 |
| Q53287209 | Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. |
| Q24598482 | Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q100430759 | Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation |
| Q57948931 | CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines |
| Q57948975 | CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines |
| Q36998293 | COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration |
| Q45117042 | CYP1A1, cigarette smoking, and colon and rectal cancer |
| Q92005489 | Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families |
| Q114657791 | Cancer Risks Associated With and Pathogenic Variants |
| Q35248795 | Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. |
| Q57907575 | Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing |
| Q34963894 | Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q33909652 | Celiac disease and human leukocyte antigen genotype: accuracy of diagnosis in self-diagnosed individuals, dosage effect, and sibling risk |
| Q59548809 | Characterization of Common BRCA1 and BRCA2 Variants |
| Q96962174 | Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q37249356 | Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation |
| Q35914568 | Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival |
| Q55210447 | Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices. |
| Q37072631 | Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives |
| Q30992909 | Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q36839777 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34394665 | Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction |
| Q35889575 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q24655824 | Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q33742096 | Common genetic variants and modification of penetrance of BRCA2-associated breast cancer |
| Q34949394 | Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers |
| Q36393232 | Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers |
| Q35870067 | Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q37434133 | Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34213403 | Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers |
| Q40718941 | Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations |
| Q28652730 | Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing |
| Q122925877 | Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment |
| Q57266620 | Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer |
| Q42365370 | Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience |
| Q34618279 | Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease |
| Q21144874 | DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q41860814 | DNA sequence variation within maize and melon: observations from polymerase chain reaction amplification and direct sequencing |
| Q33343632 | DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus |
| Q34285275 | Detailed comparison of two popular variant calling packages for exome and targeted exon studies |
| Q36144591 | Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations |
| Q44977905 | Dietary calcium, vitamin D, VDR genotypes and colorectal cancer |
| Q40060771 | Discovery of mutations in homologous recombination genes in African-American women with breast cancer |
| Q90904798 | Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers? |
| Q41221895 | Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? |
| Q34039438 | Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q57266745 | Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group |
| Q47614988 | Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers |
| Q38331039 | Energy balance, insulin-related genes and risk of colon and rectal cancer |
| Q47157633 | Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk |
| Q56968663 | Erratum: Corrigendum: Multiple common variants for celiac disease influencing immune gene expression |
| Q33814016 | Ethnic differences in cancer risk resulting from genetic variation |
| Q36890898 | Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer |
| Q33614244 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers |
| Q37481884 | Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). |
| Q36352389 | Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers |
| Q35033749 | Evaluation of restriction fragment length polymorphism in Cucumis melo |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q35032028 | Exome sequencing of 75 individuals from multiply affected coeliac families and large scale resequencing follow up. |
| Q35690548 | Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q73192716 | Familial prostate cancer studies in Utah |
| Q57266614 | Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations |
| Q37135256 | Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q36087170 | Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q24544179 | Founder populations and their uses for breast cancer genetics |
| Q41193996 | Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families |
| Q38640174 | Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q28468529 | Gene Expression Differences in Prostate Cancers between Young and Old Men |
| Q28290206 | Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13 |
| Q47567327 | Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network |
| Q29619206 | Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium |
| Q71102479 | Genetic heterogeneity and unmapped genes for colorectal cancer |
| Q33314347 | Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus |
| Q37227651 | Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation |
| Q35022825 | Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q35961713 | Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers |
| Q35524233 | Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent |
| Q33497961 | Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population |
| Q37467266 | Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q40060942 | Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q33927045 | Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417050 | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk |
| Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
| Q28924360 | Genome-wide association study of celiac disease in North America confirms FRMD4B as new celiac locus |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q44971816 | Genome-wide linkage analysis for celiac disease in North American families |
| Q36669056 | Genome-wide linkage analysis of 160 North American families with celiac disease |
| Q34044838 | Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method |
| Q33688687 | Genomic mutation-driven metastatic breast cancer therapy: a single center experience |
| Q71107825 | Germline BRCA1 185delAG mutations in Jewish women with breast cancer |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q35114576 | Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer |
| Q36278329 | Germline mutations in PALB2 in African-American breast cancer cases |
| Q58611475 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q34130985 | HLA DQA1-DQB1 genotypes in Bedouin families with celiac disease |
| Q42856743 | Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2 |
| Q35444717 | Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families |
| Q34385784 | Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study |
| Q35881432 | Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study |
| Q35382206 | Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers |
| Q57471595 | Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q47407492 | Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation |
| Q72046532 | High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium |
| Q47635634 | Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study |
| Q53354746 | Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. |
| Q36916140 | Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers |
| Q41115943 | Human Nail Clippings as a Source of DNA for Genetic Studies |
| Q34134850 | Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort |
| Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
| Q73670657 | Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q61448654 | Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas |
| Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q33633402 | Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation |
| Q37507426 | Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study |
| Q36774886 | Incomplete pregnancy is not associated with breast cancer risk: the California Teachers Study |
| Q37410472 | Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women |
| Q57907552 | Inherited mutations in breast cancer patients with and without multiple primary cancers |
| Q36168564 | International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers |
| Q37526595 | Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort |
| Q24796629 | Linkage analysis of HLA and candidate genes for celiac disease in a North American family-based study |
| Q34334383 | Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. |
| Q35648205 | Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas |
| Q57250691 | Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping |
| Q57949062 | Localization of the 9p Melanoma Susceptibility Locus (MLM) to a 2-cM Region between D9S736 and D9S171 |
| Q37081964 | Long-term and baseline recreational physical activity and risk of endometrial cancer: the California Teachers Study |
| Q37441255 | Long-term and recent recreational physical activity and survival after breast cancer: the California Teachers Study |
| Q94473101 | Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers |
| Q31043651 | Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q59238246 | Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study |
| Q34097339 | Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study |
| Q92860654 | Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers |
| Q33741434 | Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study |
| Q42423666 | Meta-analysis of genome-wide linkage studies in celiac disease |
| Q35576887 | Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women |
| Q49231162 | Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. |
| Q35207476 | Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes |
| Q34389571 | Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat |
| Q37362211 | Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers |
| Q61806342 | Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity |
| Q34498634 | Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study |
| Q47696751 | Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations |
| Q24608614 | Multiple common variants for celiac disease influencing immune gene expression |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q33721323 | Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2. |
| Q49024646 | Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. |
| Q34687498 | Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q34432899 | Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis |
| Q35892049 | Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study |
| Q36671223 | Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q91524809 | Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers |
| Q34162534 | Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q47701078 | Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group |
| Q36280191 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34041780 | Parents' ages at birth and risk of adult-onset hematologic malignancies among female teachers in California |
| Q35737888 | Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q35741630 | Pathology of ovarian cancers in BRCA1 and BRCA2 carriers |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q97524107 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q36494254 | Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network |
| Q36200696 | Prevalence of BRCA mutations and founder effect in high-risk Hispanic families |
| Q73012331 | Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families |
| Q34129787 | Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations |
| Q87232422 | Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q95725188 | Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers |
| Q45930533 | Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk. |
| Q73168986 | Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q36512097 | RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q28249994 | RAD51C germline mutations in breast and ovarian cancer cases from high-risk families |
| Q36785963 | Rapid progression of prostate cancer in men with a BRCA2 mutation |
| Q28730692 | Rare mutations in XRCC2 increase the risk of breast cancer |
| Q33892873 | Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort |
| Q37018109 | Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study |
| Q34385912 | Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer |
| Q43109055 | Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q33619700 | Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study |
| Q37378123 | Replication of celiac disease UK genome-wide association study results in a US population |
| Q37268628 | Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS |
| Q57908386 | Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study |
| Q47770236 | Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations |
| Q37129828 | Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study |
| Q37396377 | Risk factors for surgically removed fibroids in a large cohort of teachers |
| Q40287145 | Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted? |
| Q51794096 | Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. |
| Q34749278 | Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study |
| Q46776482 | Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers |
| Q55448893 | SNPs in inflammatory genes CCL11, CCL4 and MEFV in a fibromyalgia family study. |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q59238433 | Smoking and the risk of breast cancer among carriers of BRCA mutations |
| Q34548726 | Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update |
| Q35012736 | Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers |
| Q46053389 | Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease |
| Q34512590 | Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group |
| Q44930023 | The APCI1307K allele and breast cancer risk |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q24806109 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q34115636 | The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q90350109 | The RAD52-S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations |
| Q47563569 | The Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers without a First-Degree Relative with Breast Cancer |
| Q47560912 | The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers |
| Q35558999 | The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort |
| Q57250766 | The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% |
| Q41226231 | The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds |
| Q33784408 | The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk |
| Q37613551 | The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation |
| Q50955163 | The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. |
| Q53112682 | The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. |
| Q36451732 | The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers |
| Q51835514 | The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. |
| Q73604908 | The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2 |
| Q73742292 | The predictive value of BRCA1 and BRCA2 mutation testing |
| Q35907001 | The risk of breast cancer in women with a BRCA1 mutation from North America and Poland |
| Q38661110 | The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes |
| Q44256039 | Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers |
| Q114677146 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q46801017 | Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q34475484 | Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers |
| Q39639274 | Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations |
| Q47596129 | Vitamin K epoxide reductase expression and prostate cancer risk |
| Q40641271 | Weight gain after oophorectomy among women with a BRCA1 or BRCA2 mutation |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.